-
DBV Technologies
- Medical Director, Food & Pediatric Allergies
Bagneux
2012 - maintenant
-
Besins Healthcare
- Medical Affairs Director, Hormonotherapy & Probiotics
2006 - 2012
Provided decisive leadership and direction for Medical Affairs of company’s French Operation, with focus on guiding and supporting overall business and product strategies. Supervise, mentor, and coach 2 direct reports. Develop and implement initiatives to foster advocacy for company products. Build and manage strategic relationships with key opinion leaders, policy makers, healthcare professionals, and customer media outlets. Provide medical expertise, training, and support for corporate leaders, sales force, and product marketing teams. Skilfully represent corporate interests and serve as key scientific resource for external customers, stakeholders, conferences, and global media congress activities. Conduct medical evaluation of new opportunities targeting gynaecologic indications, and review presentation/marketing material content to ensure medical accuracy and compliance with industry and government regulations.
-
Roche Pharmaceuticals
- Medical line manager Anemia, Oncology, Supportive Care
2005 - 2006
Lead all medical activities in the Anemia and Oncology Supportive
Medical team & Key products (PEGASYS (INN: peginterferon alfa-2a, NEORECORMON (INN: epoetin beta) management and performance improvement
-
Altana Pharma
- Head of R&D, Pulmonology & Gastroenterology
Paris
2002 - 2005
Primary leadership force of R&D Department operations and projects, providing executive leadership for team of up to 20 staff comprised of Study Managers, CRAs, and Study Assistants. Defined and directed strategic programme plans focused on compliance, patient safety, and efficacy, whilst promoting optimal results for corporate objectives. Coordinated and completed Phases II and III. Sourced, secured, and managed multiple vendors.
-
Aventis Pasteur
- Vaccine Clinical Development Manager, Europe
1999 - 2002
Held chief leadership and management accountability for Medical Affairs and European Clinical Development operations, defining and directing short-/long-term strategies to build and expand corporate vaccine drug portfolio. Supervised 7 team members and oversaw clinical research activities including 3 drugs in clinical development Phases IIIb and IV. Coordinated Clinical Trial Review Team, and performed strategic review of Investigator/post-marketing studies. Devised clinical development plans and produced medical information for marketing teams, shareholders, publications, and symposiums. Forged and managed KOL relationships.
-
Théraplix, Rhône-Poulenc Rorer
- Head of Product Range & Pharmacovigilance, Hormones & Rheumatology
1995 - 1999
Clinical development plan: Sleep disorders & Hormonotherapy/Rheumatology and Over-The-Counter medications with client services (patients & pharmacists) and distribution issues, commercial alignment with marketing people
Management of Pharmacovigilance (Théraplix and Cooper)
-
Rhône-Poulenc Rorer
- International Clinical Project Physician & Biostatistician Manager
1990 - 1995
Socio-economic mission: epidemiology, incidence, prevalence, morbidity, mortality, risk factors, precision of the diagnosis, quality of life, medico-economic evaluation of asthma, choice of the competitors, clinical development plans [USA & Europe]
Coordination clinical trials on migraine, rheumatoid arthritis and dental pain
Investigator brochures, products monographs, writing of statistico-clinical reports, budget follow-up
Management of team, head of 12 statisticians
Responsible for the evaluation and production of statistico-clinical reports for the FDA TAXOTERE (INN: docetaxel) submission, phases I and II (23 clinical trials on Breast Cancer, Non-Small-Cell Lung cancer, Head and Neck Cancer)
-
Rhône-Poulenc Rorer
- Biostatistician
1990 - 1991
European launch of PROFENID IV (INN: ketoprofen), Pain & inflammation
Analysis of clinical trials, protocol writing, statistical tools for assurance quality
Design and production of protocols for various therapeutic areas
